Skip to content
Brand AI

Allergan

Controversies

Controversies tied to this brand in public sources. A listing is not a finding of fault.

Back to profile2 entries

  1. 2021

    Allergan agrees to pay up to $200 million in New York opioid settlement

    Settlement

    Allergan agreed to pay New York state and Nassau and Suffolk counties up to $200 million in a settlement related to its role in the opioid epidemic. The lawsuit claims manufacturers and distributors downplayed addiction risks; the source does not report a court determination of those claims.

    Source excerpt

    • Drug manufacturer Allergan has agreed to pay Suffolk and Nassau counties and the state of New York up to $200 million for its role in the opioid epidemic.
    Source

  2. 2018

    Opioid-related litigation

    Allergan was named alongside other pharmaceutical manufacturers and distributors in lawsuits filed by U.S. states and municipalities concerning the opioid epidemic. The litigation addressed alleged roles in the manufacture, marketing or distribution of opioids; the proceedings formed part of broader national opioid litigation.

    Source